Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Amvis Holdings.Inc. ( (JP:7071) ).
Amvis Holdings reported consolidated net sales of ¥12.94 billion for the first quarter ended December 31, 2025, up 9.9% year on year, while EBITDA and profit attributable to owners of parent declined 8.6% and 19.7% respectively, reflecting increased costs and margin pressure despite continued top-line growth. The balance sheet remained solid with total assets of ¥83.35 billion and a shareholders’ equity ratio of 44.2%, and the company kept its full-year forecast unchanged, projecting modest 5.1% sales growth but significantly lower profits, along with maintaining its dividend policy of no interim dividend and a year-end payout of ¥4 per share, signaling ongoing shareholder returns amid a profit downcycle.
The most recent analyst rating on (JP:7071) stock is a Hold with a Yen491.00 price target. To see the full list of analyst forecasts on Amvis Holdings.Inc. stock, see the JP:7071 Stock Forecast page.
More about Amvis Holdings.Inc.
Amvis Holdings, Inc. is a Tokyo-listed healthcare company that operates medical and nursing care facilities in Japan, focusing on providing specialized, long-term care services. The company targets an aging population and rising demand for medical and nursing care, positioning itself in a defensible niche within the domestic healthcare services market.
Average Trading Volume: 682,937
Technical Sentiment Signal: Sell
Current Market Cap: Yen50.34B
For a thorough assessment of 7071 stock, go to TipRanks’ Stock Analysis page.